Strategic Vision: A Global Pharma Company slide image

Strategic Vision: A Global Pharma Company

Key Financial Metrics 3,737 R&D (INR mn) 3,427 3,300 Capex (INR mn) 3,546 3,442 1,396 1,451 1,057 2,787 1,577 Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 9.1% 8.8% R&D (% of Sales) 8.2% 8.9% 8.7% 0.05 Net debt/Equity 0.18 0.16 (0.02) (0.01) Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q4FY21 Q1FY22 Q2FY22 Q3FY22 Q4FY22 12
View entire presentation